Feasibility of omitting clinical target volume for limited-disease small cell lung cancer treated with chemotherapy and intensity-modulated radiotherapy

por Cai, Shuhua, Shi, Anhui, Yu, Rong, Zhu, Guangying
Publicado 2014

Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent...

por Shi, Anhui, Zhu, Guangying, Wu, Hao, Yu, Rong, Li, Fuhai, Xu, Bo
Publicado 2010

Hypofractionated Volumetric-Modulated Arc Radiotherapy for Patients With Non-Small-Cell Lung Cancer Not Suitable for Surgery or Conventional Chemoradiotherapy or SBRT

por Shen, Junyue, Yang, Dan, Chen, Mailin, Jiang, Leilei, Dong, Xin, Li, Dongming, Yu, Rong, Yu, Huiming, Shi, Anhui
Publicado 2021

Stereotactic ablative radiotherapy of 60 Gy in eight fractions is safe for ultracentral non‐small cell lung cancer

por Yang, Dan, Cui, Jianing, Zhao, Jun, You, Jing, Yu, Rong, Yu, Huiming, Jiang, Leilei, Li, Dongming, Xu, Bo, Shi, Anhui
Publicado 2020

Cone‐beam CT radiomics features might improve the prediction of lung toxicity after SBRT in stage I NSCLC patients

por Qin, Qingjin, Shi, Anhui, Zhang, Ran, Wen, Qiang, Niu, Tianye, Chen, Jinhu, Qiu, Qingtao, Wan, Yidong, Sun, Xiaorong, Xing, Ligang
Publicado 2020

First-line atezolizumab/durvalumab plus platinum–etoposide combined with radiotherapy in extensive-stage small-cell lung cancer

por Li, Lijuan, Yang, Dan, Min, Yanmei, Liao, Anyan, Zhao, Jing, Jiang, Leilei, Dong, Xin, Deng, Wei, Yu, Huiming, Yu, Rong, Zhao, Jun, Shi, Anhui
Publicado 2023

Prediction of Clinical Outcome in Locally Advanced Non-Small Cell Lung Cancer Patients Treated With Chemoradiotherapy by Plasma Markers

por Sui, Xin, Jiang, Leilei, Teng, Huajing, Mi, Lan, Li, Bo, Shi, Anhui, Yu, Rong, Li, Dongming, Dong, Xin, Yang, Dan, Yu, Huiming, Wang, Weihu
Publicado 2021

Optimal first‐line treatment for advanced thymic carcinoma

por Yang, Xue, Zhuo, Minglei, Shi, Anhui, Yang, Shengnan, Wang, Ziping, Wu, Meina, An, Tongtong, Wang, Yuyan, Li, Jianjie, Zhong, Jia, Chen, Hanxiao, Jia, Bo, Dong, Zhi, Zhao, Jun
Publicado 2019

Phase 3 Randomized Low-Dose Paclitaxel Chemoradiotherapy Study for Locally Advanced Non-Small Cell Lung Cancer

por Lin, Hongmei, Chen, Yuhchyau, Shi, Anhui, Pandya, Kishan J., Yu, Rong, Yuan, Yannan, Li, Jiancheng, Li, Hang, Wang, Yingjie, Xia, Tingyi, Feng, Linchun, Ma, Huimin, Geng, Jianhao, Zhu, Guangying
Publicado 2016

Long-term survival and toxicity outcomes of intensity modulated radiation therapy for the treatment of esophageal cancer: A large single-institutional cohort study

por Shi, Anhui, Liao, Zhongxing, Allen, Pamela K., Ho, Linus, Murphy, Mariela Blum, Maru, Dipen M., Swisher, Stephen G., Hofstetter, Wayne L., Mehran, Reza J., Cox, James D., Komaki, Ritsuko, Lin, Steven H.
Publicado 2017

Postoperative lymphatic recurrence distribution and delineation of the radiation field in lower thoracic squamous cell esophageal carcinomas: a real-world study

por Du, Rongxu, Fan, Songqing, Wang, Xiaobin, Hou, Xia, Zeng, Cheng, Guo, Dan, Tian, Rongrong, Yang, Dan, Jiang, Leilei, Dong, Xin, Yu, Rong, Yu, Huiming, Li, Dongming, Zhu, Shuchai, Li, Jie, Shi, Anhui
Publicado 2022

Effects of Enteral Nutrition on Patients With Oesophageal Carcinoma Treated With Concurrent Chemoradiotherapy: A Prospective, Multicentre, Randomised, Controlled Study

por Lyu, Jiahua, Shi, Anhui, Li, Tao, Li, Jie, Zhao, Ren, Zhu, Shuchai, Wang, Jianhua, Xing, Ligang, Yang, Daoke, Xie, Conghua, Shen, Liangfang, Zhang, Hailin, Zhu, Guangying, Wang, Jing, Pan, Wenyan, Li, Fang, Lang, Jinyi, Shi, Hanping
Publicado 2022

Efficacy and safety of concurrent chemoradiotherapy in ECOG 2 patients with locally advanced non-small-cell lung cancer: a subgroup analysis of a randomized phase III trial

por Bi, Nan, Liu, Lipin, Liang, Jun, Wu, Shixiu, Chen, Ming, Lv, Changxing, Zhao, Lujun, Shi, Anhui, Jiang, Wei, Xu, Yaping, Zhou, Zongmei, Wang, Jingbo, Wang, Wenqing, Chen, Dongfu, Hui, Zhouguang, Lv, Jima, Zhang, Hongxing, Feng, Qinfu, Xiao, Zefen, Wang, Xin, Zhang, Tao, Yin, Weibo, Li, Junling, He, Jie, Wang, Luhua
Publicado 2020